315 related articles for article (PubMed ID: 32787374)
21. [A Case in Which Eating Ability Was Restored after Chemotherapy for Gastric Metastasis Following Colon Cancer Resection].
Ohashi I; Arai I; Tamura C; Hayashi N; Inoue S; Wakasa T
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2103-5. PubMed ID: 26805278
[TBL] [Abstract][Full Text] [Related]
22. Durvalumab-induced Immune-related Hepatitis in a Patient with Non-small Cell Lung Cancer.
Nakamura M; Otsuka T; Hayashi R; Horita T; Ota M; Sakurai N; Takano H; Hayashi T; Kumagai M; Yamada S; Arisawa T
Intern Med; 2020 Nov; 59(21):2711-2717. PubMed ID: 32669493
[TBL] [Abstract][Full Text] [Related]
23. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
[No Abstract] [Full Text] [Related]
24. Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial.
Powles T; van der Heijden MS; Castellano D; Galsky MD; Loriot Y; Petrylak DP; Ogawa O; Park SH; Lee JL; De Giorgi U; Bögemann M; Bamias A; Eigl BJ; Gurney H; Mukherjee SD; Fradet Y; Skoneczna I; Tsiatas M; Novikov A; Suárez C; Fay AP; Duran I; Necchi A; Wildsmith S; He P; Angra N; Gupta AK; Levin W; Bellmunt J;
Lancet Oncol; 2020 Dec; 21(12):1574-1588. PubMed ID: 32971005
[TBL] [Abstract][Full Text] [Related]
25. Concurrent irradiation with the anti-programmed cell death ligand-1 immune checkpoint blocker durvalumab: Single centre subset analysis from a phase 1/2 trial.
Levy A; Massard C; Soria JC; Deutsch E
Eur J Cancer; 2016 Nov; 68():156-162. PubMed ID: 27764686
[TBL] [Abstract][Full Text] [Related]
26. Pathological complete response to radical surgery after receiving durvalumab plus neoadjuvant chemotherapy for 1 limited-stage small cell lung cancer patient: a case report.
Li Z; Zhang B; Yang F; Yang L
Transl Cancer Res; 2022 Apr; 11(4):973-979. PubMed ID: 35571672
[TBL] [Abstract][Full Text] [Related]
27. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
[No Abstract] [Full Text] [Related]
28. FOLFOX or CAPOX in Stage II to III Colon Cancer: Efficacy Results of the Italian Three or Six Colon Adjuvant Trial.
Sobrero A; Lonardi S; Rosati G; Di Bartolomeo M; Ronzoni M; Pella N; Scartozzi M; Banzi M; Zampino MG; Pasini F; Marchetti P; Cantore M; Zaniboni A; Rimassa L; Ciuffreda L; Ferrari D; Zagonel V; Maiello E; Barni S; Rulli E; Labianca R;
J Clin Oncol; 2018 May; 36(15):1478-1485. PubMed ID: 29620994
[TBL] [Abstract][Full Text] [Related]
29. [Safety and effectiveness of oxaliplatin combined with capecitabine or oxaliplatin combined with S-1 neoadjuvant chemotherapy in the treatment of advanced gastric cancer].
Xie BW; Zang L; Ma JJ; Sun J; Yang X; Wang ML; Lu AG; Hu WG; Zheng MH
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):138-144. PubMed ID: 33508919
[No Abstract] [Full Text] [Related]
30. A Mismatch Repair-Deficient Hepatoid Adenocarcinoma of the Lung Responding to Anti-PD-L1 Durvalumab Therapy Despite no PD-L1 Expression.
Basse V; Schick U; Guéguen P; Le Maréchal C; Quintin-Roué I; Descourt R; Simon H; Uguen A; Quéré G
J Thorac Oncol; 2018 Jul; 13(7):e120-e122. PubMed ID: 29935850
[No Abstract] [Full Text] [Related]
31. Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or stable after olaparib treatment.
Fumet JD; Limagne E; Thibaudin M; Truntzer C; Bertaut A; Rederstorff E; Ghiringhelli F
BMC Cancer; 2020 Aug; 20(1):748. PubMed ID: 32778095
[TBL] [Abstract][Full Text] [Related]
32. Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trial.
Zamarin D; Walderich S; Holland A; Zhou Q; Iasonos AE; Torrisi JM; Merghoub T; Chesebrough LF; Mcdonnell AS; Gallagher JM; Li Y; Hollmann TJ; Grisham RN; Erskine CL; Block MS; Knutson KL; O'Cearbhaill RE; Aghajanian C; Konner JA
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32503949
[TBL] [Abstract][Full Text] [Related]
33. [Three cases of resected pulmonary metastasis from colorectal cancer after preoperative chemotherapy].
Imaizumi K; Koshiishi H; Nakata T; Matsuyama T; Hirano T; Okuno K; Yoshimura T; Ebana H; Ikeda N
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2056-8. PubMed ID: 25731421
[TBL] [Abstract][Full Text] [Related]
34. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
[No Abstract] [Full Text] [Related]
35. Immunotherapy for pulmonary squamous cell carcinoma and colon carcinoma with pembrolizumab: A case report.
Nozawa Y; Oka Y; Oosugi J; Takemura S
Medicine (Baltimore); 2018 May; 97(19):e0718. PubMed ID: 29742733
[TBL] [Abstract][Full Text] [Related]
36. [A case of advanced colon cancer successfully treated with combination therapy of cetuximab and oxaliplatin, leucovorin, and 5-fluorouracil].
Ojima E; Nakano T; Kanamoto A; Sasaki S
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1962-4. PubMed ID: 24393980
[TBL] [Abstract][Full Text] [Related]
37. FDG-PET in the evaluation of response to nivolumab in recurrent non-small-cell lung cancer.
Higuchi M; Owada Y; Inoue T; Watanabe Y; Yamaura T; Fukuhara M; Hasegawa T; Suzuki H
World J Surg Oncol; 2016 Sep; 14(1):238. PubMed ID: 27595749
[TBL] [Abstract][Full Text] [Related]
38. A case of dMMR/MSI-H/TMB-H colon cancer with brain metastasis treated with PD-1 monoclonal antibody.
Xiang T; Zhang H; Fang W; Chen W
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 53(1):58-63. PubMed ID: 38413220
[TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy of durvalumab in patients with head and neck squamous cell carcinoma: results from a phase I/II expansion cohort.
Segal NH; Ou SI; Balmanoukian A; Fury MG; Massarelli E; Brahmer JR; Weiss J; Schöffski P; Antonia SJ; Massard C; Zandberg DP; Khleif SN; Xiao F; Rebelatto MC; Steele KE; Robbins PB; Angra N; Song X; Abdullah S; Butler M
Eur J Cancer; 2019 Mar; 109():154-161. PubMed ID: 30731276
[TBL] [Abstract][Full Text] [Related]
40. Breast metastasis of signet ring cell carcinoma from the colon: a case report.
Wang X; Zhang H; Lu Y
World J Surg Oncol; 2022 Dec; 20(1):376. PubMed ID: 36451153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
